See also this year's filing and all EDGAR filings for this company.
PDF Report 0001492422_2020_Apellis_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001492422, Apellis Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 373,094,684 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,654,999 |
| 3 | remainder_Assets | 14,495,297 |
| 4 | LiabilitiesCurrent | 65,752,819 |
| 5 | LiabilitiesNoncurrent | 11,856,634 |
| 6 | remainder_Liabilities | 277,405,851 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 5,284,610 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -299,422,003 |
| 13 | remainder_ComprehensiveNetIncome | -30,968 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 389,244,980 |
| 1 | Liabilities | 355,015,304 |
| 2 | Expenses | 5,284,610 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 34,229,676 |
| 5 | NetIncome | -304,706,613 |
| 6 | ComprehensiveNetIncome | -304,722,097 |
| 7 | BaseVar | 524,498,932 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.618 |
| 9 | EconomicCapitalRatio | 1.37 |
Edgar->Model Mapping
Feature Distribution
Change over Time
